Background: Schnitzler’s syndrome is an autoinflammatory disease characterized by monoclonal gammopathy and recurrent episodes of urticaria accompanied clinical laboratory signs acute inflammation. Interleukin (IL)-1 inhibitors proved to be useful in the treatment, but data on long-term safety efficacy these agents are sparse. Objectives: To evaluate retention rate IL-1 patients with Syndrome. ...